Wells Fargo’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $96.3K | Buy |
25,967
+2,313
| +10% | +$8.58K | ﹤0.01% | 4807 |
|
|
2025
Q1 | $76.4K | Sell |
23,654
-2,198
| -9% | -$7.1K | ﹤0.01% | 4786 |
|
|
2024
Q4 | $144K | Buy |
25,852
+7,463
| +41% | +$41.6K | ﹤0.01% | 4500 |
|
|
2024
Q3 | $199K | Buy |
18,389
+144
| +0.8% | +$1.56K | ﹤0.01% | 4201 |
|
|
2024
Q2 | $383K | Buy |
18,245
+3,900
| +27% | +$81.9K | ﹤0.01% | 3736 |
|
|
2024
Q1 | $457K | Buy |
14,345
+2,071
| +17% | +$66K | ﹤0.01% | 3610 |
|
|
2023
Q4 | $249K | Sell |
12,274
-19,821
| -62% | -$402K | ﹤0.01% | 3956 |
|
|
2023
Q3 | $409K | Sell |
32,095
-6,988
| -18% | -$89K | ﹤0.01% | 3626 |
|
|
2023
Q2 | $706K | Buy |
39,083
+11,095
| +40% | +$200K | ﹤0.01% | 3512 |
|
|
2023
Q1 | $481K | Buy |
27,988
+27,788
| +13,894% | +$478K | ﹤0.01% | 3631 |
|
|
2022
Q4 | $4.44K | Sell |
200
-69
| -26% | -$1.53K | ﹤0.01% | 5484 |
|
|
2022
Q3 | $3K | Sell |
269
-279
| -51% | -$3.11K | ﹤0.01% | 5715 |
|
|
2022
Q2 | $3K | Sell |
548
-10,531
| -95% | -$57.7K | ﹤0.01% | 5876 |
|
|
2022
Q1 | $168K | Sell |
11,079
-9,155
| -45% | -$139K | ﹤0.01% | 4770 |
|
|
2021
Q4 | $444K | Buy |
20,234
+12,550
| +163% | +$275K | ﹤0.01% | 4438 |
|
|
2021
Q3 | $206K | Buy |
7,684
+6,859
| +831% | +$184K | ﹤0.01% | 4798 |
|
|
2021
Q2 | $20K | Sell |
825
-1,615
| -66% | -$39.2K | ﹤0.01% | 5566 |
|
|
2021
Q1 | $106K | Buy |
+2,440
| New | +$106K | ﹤0.01% | 5115 |
|